nx-1607
nurix therapeutics
['solid tumor', 'nx-1607 ']
the icr/ ' dr adam sharp ( ) will present on a first-in-human phase 1 trial of nx-1607 in patients with advanced solid tumor malignancies in the #asco22 poster session. 5th june 2022, 08:00 cdt abstract tps2691 
The Institute of Cancer Research is making the discoveries that defeat cancer. We're the UK's top academic research centre, a postgrad college, and a charity.